nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—allergic rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.365	1	CpDpCtD
Pseudoephedrine—TNF—chronic obstructive pulmonary disease	0.101	0.372	CbGaD
Pseudoephedrine—ADRB2—chronic obstructive pulmonary disease	0.0899	0.329	CbGaD
Pseudoephedrine—SLC6A4—chronic obstructive pulmonary disease	0.0817	0.299	CbGaD
Pseudoephedrine—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0447	0.18	CbGbCtD
Pseudoephedrine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.044	0.178	CbGbCtD
Pseudoephedrine—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0339	0.137	CbGbCtD
Pseudoephedrine—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0339	0.137	CbGbCtD
Pseudoephedrine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0333	0.135	CbGbCtD
Pseudoephedrine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0333	0.135	CbGbCtD
Pseudoephedrine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00849	0.0343	CbGbCtD
Pseudoephedrine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00849	0.0343	CbGbCtD
Pseudoephedrine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00757	0.0306	CbGbCtD
Pseudoephedrine—Prostatic hypertrophy—Tiotropium—chronic obstructive pulmonary disease	0.00599	0.127	CcSEcCtD
Pseudoephedrine—Benign prostatic hyperplasia—Tiotropium—chronic obstructive pulmonary disease	0.00326	0.0688	CcSEcCtD
Pseudoephedrine—IL2—respiratory system—chronic obstructive pulmonary disease	0.00176	0.146	CbGeAlD
Pseudoephedrine—NFATC1—connective tissue—chronic obstructive pulmonary disease	0.00169	0.141	CbGeAlD
Pseudoephedrine—IL2—connective tissue—chronic obstructive pulmonary disease	0.00155	0.129	CbGeAlD
Pseudoephedrine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.0235	CcSEcCtD
Pseudoephedrine—NFATC1—lung—chronic obstructive pulmonary disease	0.00102	0.0848	CbGeAlD
Pseudoephedrine—IL2—lung—chronic obstructive pulmonary disease	0.000933	0.0776	CbGeAlD
Pseudoephedrine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.000712	0.015	CcSEcCtD
Pseudoephedrine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.0115	CcSEcCtD
Pseudoephedrine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.000542	0.0115	CcSEcCtD
Pseudoephedrine—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.0113	CcSEcCtD
Pseudoephedrine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.011	CcSEcCtD
Pseudoephedrine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.0108	CcSEcCtD
Pseudoephedrine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000464	0.0386	CbGeAlD
Pseudoephedrine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00964	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00964	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.0091	CcSEcCtD
Pseudoephedrine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000425	0.0354	CbGeAlD
Pseudoephedrine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000415	0.00877	CcSEcCtD
Pseudoephedrine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.00874	CcSEcCtD
Pseudoephedrine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00824	CcSEcCtD
Pseudoephedrine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000387	0.0322	CbGeAlD
Pseudoephedrine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000385	0.00815	CcSEcCtD
Pseudoephedrine—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00814	CcSEcCtD
Pseudoephedrine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000381	0.00806	CcSEcCtD
Pseudoephedrine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000377	0.00798	CcSEcCtD
Pseudoephedrine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000374	0.0311	CbGeAlD
Pseudoephedrine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00782	CcSEcCtD
Pseudoephedrine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000368	0.00778	CcSEcCtD
Pseudoephedrine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000362	0.0301	CbGeAlD
Pseudoephedrine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000353	0.00746	CcSEcCtD
Pseudoephedrine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000347	0.00734	CcSEcCtD
Pseudoephedrine—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.0073	CcSEcCtD
Pseudoephedrine—MAOA—respiratory system—chronic obstructive pulmonary disease	0.000345	0.0287	CbGeAlD
Pseudoephedrine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000333	0.00704	CcSEcCtD
Pseudoephedrine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.000331	0.00701	CcSEcCtD
Pseudoephedrine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00654	CcSEcCtD
Pseudoephedrine—MAOA—connective tissue—chronic obstructive pulmonary disease	0.000304	0.0253	CbGeAlD
Pseudoephedrine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.0063	CcSEcCtD
Pseudoephedrine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00029	0.00613	CcSEcCtD
Pseudoephedrine—MAOA—bronchus—chronic obstructive pulmonary disease	0.000284	0.0236	CbGeAlD
Pseudoephedrine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000282	0.00596	CcSEcCtD
Pseudoephedrine—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00589	CcSEcCtD
Pseudoephedrine—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00589	CcSEcCtD
Pseudoephedrine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000278	0.00589	CcSEcCtD
Pseudoephedrine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00568	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000264	0.00558	CcSEcCtD
Pseudoephedrine—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00556	CcSEcCtD
Pseudoephedrine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00543	CcSEcCtD
Pseudoephedrine—MAOA—trachea—chronic obstructive pulmonary disease	0.000255	0.0212	CbGeAlD
Pseudoephedrine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00538	CcSEcCtD
Pseudoephedrine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00536	CcSEcCtD
Pseudoephedrine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00534	CcSEcCtD
Pseudoephedrine—SLC6A3—lung—chronic obstructive pulmonary disease	0.000246	0.0205	CbGeAlD
Pseudoephedrine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000245	0.00519	CcSEcCtD
Pseudoephedrine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00509	CcSEcCtD
Pseudoephedrine—ADRB1—lung—chronic obstructive pulmonary disease	0.000234	0.0194	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000233	0.0194	CbGeAlD
Pseudoephedrine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00489	CcSEcCtD
Pseudoephedrine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00488	CcSEcCtD
Pseudoephedrine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00023	0.00486	CcSEcCtD
Pseudoephedrine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000226	0.0188	CbGeAlD
Pseudoephedrine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00472	CcSEcCtD
Pseudoephedrine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000222	0.0047	CcSEcCtD
Pseudoephedrine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000218	0.00461	CcSEcCtD
Pseudoephedrine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000218	0.0181	CbGeAlD
Pseudoephedrine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00451	CcSEcCtD
Pseudoephedrine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00448	CcSEcCtD
Pseudoephedrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000212	0.00448	CcSEcCtD
Pseudoephedrine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00444	CcSEcCtD
Pseudoephedrine—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00441	CcSEcCtD
Pseudoephedrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00441	CcSEcCtD
Pseudoephedrine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00432	CcSEcCtD
Pseudoephedrine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00432	CcSEcCtD
Pseudoephedrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000204	0.00431	CcSEcCtD
Pseudoephedrine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00431	CcSEcCtD
Pseudoephedrine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000202	0.00427	CcSEcCtD
Pseudoephedrine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000202	0.00427	CcSEcCtD
Pseudoephedrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000201	0.00424	CcSEcCtD
Pseudoephedrine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000199	0.0165	CbGeAlD
Pseudoephedrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00416	CcSEcCtD
Pseudoephedrine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000196	0.0163	CbGeAlD
Pseudoephedrine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00413	CcSEcCtD
Pseudoephedrine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00413	CcSEcCtD
Pseudoephedrine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00409	CcSEcCtD
Pseudoephedrine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00409	CcSEcCtD
Pseudoephedrine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00409	CcSEcCtD
Pseudoephedrine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00408	CcSEcCtD
Pseudoephedrine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00405	CcSEcCtD
Pseudoephedrine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00405	CcSEcCtD
Pseudoephedrine—Ephedrine—ADRB2—chronic obstructive pulmonary disease	0.000191	0.126	CrCbGaD
Pseudoephedrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00019	0.00402	CcSEcCtD
Pseudoephedrine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00398	CcSEcCtD
Pseudoephedrine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00397	CcSEcCtD
Pseudoephedrine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00395	CcSEcCtD
Pseudoephedrine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00395	CcSEcCtD
Pseudoephedrine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00393	CcSEcCtD
Pseudoephedrine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0039	CcSEcCtD
Pseudoephedrine—MAOA—lung—chronic obstructive pulmonary disease	0.000183	0.0152	CbGeAlD
Pseudoephedrine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00387	CcSEcCtD
Pseudoephedrine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00387	CcSEcCtD
Pseudoephedrine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00387	CcSEcCtD
Pseudoephedrine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00386	CcSEcCtD
Pseudoephedrine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00385	CcSEcCtD
Pseudoephedrine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00382	CcSEcCtD
Pseudoephedrine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00379	CcSEcCtD
Pseudoephedrine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.00375	CcSEcCtD
Pseudoephedrine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00373	CcSEcCtD
Pseudoephedrine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00372	CcSEcCtD
Pseudoephedrine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00372	CcSEcCtD
Pseudoephedrine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00366	CcSEcCtD
Pseudoephedrine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00365	CcSEcCtD
Pseudoephedrine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00364	CcSEcCtD
Pseudoephedrine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00364	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB2—chronic obstructive pulmonary disease	0.000171	0.113	CrCbGaD
Pseudoephedrine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00359	CcSEcCtD
Pseudoephedrine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00359	CcSEcCtD
Pseudoephedrine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00357	CcSEcCtD
Pseudoephedrine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00357	CcSEcCtD
Pseudoephedrine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00357	CcSEcCtD
Pseudoephedrine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00357	CcSEcCtD
Pseudoephedrine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00352	CcSEcCtD
Pseudoephedrine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000166	0.0035	CcSEcCtD
Pseudoephedrine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00343	CcSEcCtD
Pseudoephedrine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00339	CcSEcCtD
Pseudoephedrine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00337	CcSEcCtD
Pseudoephedrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00336	CcSEcCtD
Pseudoephedrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00336	CcSEcCtD
Pseudoephedrine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00326	CcSEcCtD
Pseudoephedrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00317	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00314	CcSEcCtD
Pseudoephedrine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00311	CcSEcCtD
Pseudoephedrine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00311	CcSEcCtD
Pseudoephedrine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00309	CcSEcCtD
Pseudoephedrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00307	CcSEcCtD
Pseudoephedrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00307	CcSEcCtD
Pseudoephedrine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00305	CcSEcCtD
Pseudoephedrine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00303	CcSEcCtD
Pseudoephedrine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00303	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.0938	CrCbGaD
Pseudoephedrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.00299	CcSEcCtD
Pseudoephedrine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000141	0.0117	CbGeAlD
Pseudoephedrine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00296	CcSEcCtD
Pseudoephedrine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00294	CcSEcCtD
Pseudoephedrine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00294	CcSEcCtD
Pseudoephedrine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00294	CcSEcCtD
Pseudoephedrine—Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.000138	0.0918	CrCbGaD
Pseudoephedrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00289	CcSEcCtD
Pseudoephedrine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00288	CcSEcCtD
Pseudoephedrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.00287	CcSEcCtD
Pseudoephedrine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00286	CcSEcCtD
Pseudoephedrine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00285	CcSEcCtD
Pseudoephedrine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00285	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00283	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00283	CcSEcCtD
Pseudoephedrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.00283	CcSEcCtD
Pseudoephedrine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00282	CcSEcCtD
Pseudoephedrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.00282	CcSEcCtD
Pseudoephedrine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00278	CcSEcCtD
Pseudoephedrine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00272	CcSEcCtD
Pseudoephedrine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00272	CcSEcCtD
Pseudoephedrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.00271	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00269	CcSEcCtD
Pseudoephedrine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.00269	CcSEcCtD
Pseudoephedrine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.00268	CcSEcCtD
Pseudoephedrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00268	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00268	CcSEcCtD
Pseudoephedrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000126	0.00267	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00267	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0836	CrCbGaD
Pseudoephedrine—Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.0836	CrCbGaD
Pseudoephedrine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00266	CcSEcCtD
Pseudoephedrine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00263	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.0806	CrCbGaD
Pseudoephedrine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00257	CcSEcCtD
Pseudoephedrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.00253	CcSEcCtD
Pseudoephedrine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00247	CcSEcCtD
Pseudoephedrine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00247	CcSEcCtD
Pseudoephedrine—Selegiline—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.0773	CrCbGaD
Pseudoephedrine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00242	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00234	CcSEcCtD
Pseudoephedrine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00233	CcSEcCtD
Pseudoephedrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00227	CcSEcCtD
Pseudoephedrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00227	CcSEcCtD
Pseudoephedrine—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000106	0.0706	CrCbGaD
Pseudoephedrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00223	CcSEcCtD
Pseudoephedrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00219	CcSEcCtD
Pseudoephedrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00219	CcSEcCtD
Pseudoephedrine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00217	CcSEcCtD
Pseudoephedrine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00217	CcSEcCtD
Pseudoephedrine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00217	CcSEcCtD
Pseudoephedrine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00217	CcSEcCtD
Pseudoephedrine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00215	CcSEcCtD
Pseudoephedrine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00215	CcSEcCtD
Pseudoephedrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00215	CcSEcCtD
Pseudoephedrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00214	CcSEcCtD
Pseudoephedrine—Rash—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00212	CcSEcCtD
Pseudoephedrine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00212	CcSEcCtD
Pseudoephedrine—Headache—Montelukast—chronic obstructive pulmonary disease	9.98e-05	0.00211	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	9.86e-05	0.0654	CrCbGaD
Pseudoephedrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.76e-05	0.00206	CcSEcCtD
Pseudoephedrine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	9.71e-05	0.0643	CrCbGaD
Pseudoephedrine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.69e-05	0.00205	CcSEcCtD
Pseudoephedrine—Rash—Salbutamol—chronic obstructive pulmonary disease	9.68e-05	0.00205	CcSEcCtD
Pseudoephedrine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.00205	CcSEcCtD
Pseudoephedrine—Nausea—Formoterol—chronic obstructive pulmonary disease	9.66e-05	0.00204	CcSEcCtD
Pseudoephedrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.66e-05	0.00204	CcSEcCtD
Pseudoephedrine—Headache—Salbutamol—chronic obstructive pulmonary disease	9.62e-05	0.00203	CcSEcCtD
Pseudoephedrine—Nausea—Montelukast—chronic obstructive pulmonary disease	9.46e-05	0.002	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.32e-05	0.00197	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.00194	CcSEcCtD
Pseudoephedrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.12e-05	0.00193	CcSEcCtD
Pseudoephedrine—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.00189	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.00182	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.51e-05	0.0018	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.0017	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.96e-05	0.00168	CcSEcCtD
Pseudoephedrine—Pain—Prednisolone—chronic obstructive pulmonary disease	7.53e-05	0.00159	CcSEcCtD
Pseudoephedrine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	7.46e-05	0.0495	CrCbGaD
Pseudoephedrine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.00153	CcSEcCtD
Pseudoephedrine—Agitation—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.00152	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.00149	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.00143	CcSEcCtD
Pseudoephedrine—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.00141	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.00132	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.00131	CcSEcCtD
Pseudoephedrine—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.00129	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.82e-05	0.00123	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.00122	CcSEcCtD
Pseudoephedrine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.00119	CcSEcCtD
Pseudoephedrine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.00118	CcSEcCtD
Pseudoephedrine—Rash—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.00117	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.55e-05	0.00117	CcSEcCtD
Pseudoephedrine—Headache—Prednisolone—chronic obstructive pulmonary disease	5.52e-05	0.00117	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.00112	CcSEcCtD
Pseudoephedrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.23e-05	0.00111	CcSEcCtD
Pseudoephedrine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.00107	CcSEcCtD
Pseudoephedrine—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.000971	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000895	CcSEcCtD
Pseudoephedrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.07e-05	0.00086	CcSEcCtD
Pseudoephedrine—Rash—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000853	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000852	CcSEcCtD
Pseudoephedrine—Headache—Prednisone—chronic obstructive pulmonary disease	4.01e-05	0.000848	CcSEcCtD
Pseudoephedrine—Nausea—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000804	CcSEcCtD
Pseudoephedrine—IL2—Hemostasis—TP53—chronic obstructive pulmonary disease	1.29e-05	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.29e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.27e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.27e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.26e-05	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.26e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1B—chronic obstructive pulmonary disease	1.25e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.25e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.24e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.23e-05	0.000229	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.21e-05	0.000226	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000226	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—LEP—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.18e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000219	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.17e-05	0.000217	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	1.16e-05	0.000217	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.13e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.12e-05	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.11e-05	0.000206	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.09e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	1.08e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.07e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.07e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.07e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.07e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1B—chronic obstructive pulmonary disease	1.06e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	1.06e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.05e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.04e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.01e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.97e-06	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.85e-06	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.8e-06	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.71e-06	0.000181	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.68e-06	0.000181	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—chronic obstructive pulmonary disease	9.55e-06	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.52e-06	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.5e-06	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.42e-06	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	9.18e-06	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.18e-06	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.1e-06	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9e-06	0.000168	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—chronic obstructive pulmonary disease	8.99e-06	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.98e-06	0.000167	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.84e-06	0.000165	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—chronic obstructive pulmonary disease	8.82e-06	0.000164	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.66e-06	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.65e-06	0.000161	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	8.56e-06	0.00016	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.45e-06	0.000158	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.44e-06	0.000157	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—chronic obstructive pulmonary disease	8.08e-06	0.000151	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.05e-06	0.00015	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.96e-06	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.86e-06	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.86e-06	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	7.83e-06	0.000146	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	7.81e-06	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	7.75e-06	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.73e-06	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	7.73e-06	0.000144	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.64e-06	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	7.59e-06	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.56e-06	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.43e-06	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.4e-06	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.39e-06	0.000138	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—chronic obstructive pulmonary disease	7.34e-06	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.3e-06	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.24e-06	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.23e-06	0.000135	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—chronic obstructive pulmonary disease	7.23e-06	0.000135	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.2e-06	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	7.19e-06	0.000134	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.14e-06	0.000133	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.1e-06	0.000132	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.05e-06	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.02e-06	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7e-06	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	6.97e-06	0.00013	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	6.9e-06	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.9e-06	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.87e-06	0.000128	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.86e-06	0.000128	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.79e-06	0.000127	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—chronic obstructive pulmonary disease	6.78e-06	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.76e-06	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.62e-06	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.5e-06	0.000121	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.49e-06	0.000121	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.46e-06	0.000121	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.42e-06	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.36e-06	0.000119	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.3e-06	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.26e-06	0.000117	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—chronic obstructive pulmonary disease	6.21e-06	0.000116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.17e-06	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.14e-06	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.01e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	6e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.99e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.98e-06	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.96e-06	0.000111	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.96e-06	0.000111	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.92e-06	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.91e-06	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	5.87e-06	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	5.86e-06	0.000109	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.84e-06	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.81e-06	0.000108	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.8e-06	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.79e-06	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	5.72e-06	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.68e-06	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	5.6e-06	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.56e-06	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.56e-06	0.000104	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.52e-06	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.47e-06	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.41e-06	0.000101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.33e-06	9.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.29e-06	9.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.28e-06	9.84e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-06	9.75e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.22e-06	9.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	5.22e-06	9.74e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.18e-06	9.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.08e-06	9.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.03e-06	9.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.97e-06	9.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.92e-06	9.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.81e-06	8.97e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.74e-06	8.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.64e-06	8.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.62e-06	8.61e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.49e-06	8.37e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.38e-06	8.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.38e-06	8.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.18e-06	7.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.15e-06	7.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.09e-06	7.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.07e-06	7.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.07e-06	7.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.06e-06	7.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.04e-06	7.53e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.01e-06	7.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.01e-06	7.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.96e-06	7.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.79e-06	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.78e-06	7.05e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.77e-06	7.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.77e-06	7.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.76e-06	7e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.73e-06	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.71e-06	6.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.71e-06	6.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.69e-06	6.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.69e-06	6.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.63e-06	6.77e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	3.56e-06	6.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.55e-06	6.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.49e-06	6.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.49e-06	6.51e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.4e-06	6.34e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-06	6.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.38e-06	6.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.37e-06	6.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.36e-06	6.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.3e-06	6.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.14e-06	5.86e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.13e-06	5.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.12e-06	5.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.07e-06	5.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.05e-06	5.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.05e-06	5.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.94e-06	5.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.85e-06	5.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.83e-06	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.77e-06	5.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.73e-06	5.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.73e-06	5.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.71e-06	5.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.65e-06	4.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.61e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.59e-06	4.83e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.58e-06	4.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.54e-06	4.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.53e-06	4.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.47e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.4e-06	4.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	2.38e-06	4.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.28e-06	4.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.27e-06	4.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.24e-06	4.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.24e-06	4.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.19e-06	4.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.14e-06	3.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.13e-06	3.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.09e-06	3.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.09e-06	3.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.04e-06	3.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.03e-06	3.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.99e-06	3.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.98e-06	3.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.9e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.82e-06	3.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.81e-06	3.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.78e-06	3.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.72e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.69e-06	3.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.67e-06	3.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.64e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.64e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.63e-06	3.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.6e-06	2.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.6e-06	2.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.55e-06	2.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.52e-06	2.84e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-06	2.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.47e-06	2.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.38e-06	2.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.37e-06	2.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.35e-06	2.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.35e-06	2.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.33e-06	2.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.26e-06	2.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.23e-06	2.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.23e-06	2.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.11e-06	2.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.03e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.02e-06	1.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.47e-07	1.77e-05	CbGpPWpGaD
